Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
DBVT | NASDAQ | USD | Real-time | |
DBVp | BATS Europe | EUR | Delayed | |
DBV | Paris | EUR | Real-time |
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow’s milk protein allergy and eosinophilic esophagitis. The company’s earlier stage research programs includes vaccine for the respiratory syncytial virus, potential treatments for inflammatory bowel disease, celiac disease, and type I diabetes. In addition, it develops Viaskin technology platform, a platform to potentially treat food allergy. The company has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Montrouge, France.
Name | Age | Since | Title |
---|---|---|---|
Pierre-Henri Benhamou | 66 | 2002 | Co-Founder & Member of Scientific Advisory Board |
Gideon Lack | - | - | Member of the Scientific Advisory Board |
Jonathan M. Spergel | - | - | Member of the Scientific Advisory Board |
Michael Rosenblum | - | 2019 | Member of Scientific Advisory Board |
Christophe Dupont | - | - | Member of Advisory Board |
Ravi Madduri Rao | 55 | 2021 | Independent Director |
Emma Guttman-Yassky | - | 2019 | Member of Scientific Advisory Board |
Jim Krueger | - | 2019 | Member of Scientific Advisory Board |
Miriam Merad | - | 2019 | Member of Scientific Advisory Board |
Jean-François Nicolas | - | 2019 | Member of Scientific Advisory Board |
Adora Ndu | 41 | 2021 | Independent Director |
Betty A. Diamond | - | 2021 | Member of Scientific Advisory Board |
Daniele Guyot-Caparros | 64 | 2022 | Independent Director |
Michel de Rosen | 72 | 2018 | Independent Chairman of the Board |
Hugh A. Sampson | 74 | 2015 | Scientific Adviser to the CEO & Chairman of Scientific Advisory Board |
Michael J. Goller | 48 | 2015 | Director |
Daniel Tassé | 63 | 2018 | CEO & Director |
Mailys Ferrere | 61 | 2012 | Director |
Paul-Henri Lambert | 84 | - | Member of the Scientific Advisory Board |
Daniel B. Soland | 67 | 2015 | Independent Director |
Timothy E. Morris | 62 | 2021 | Independent Director |
Julie O'Neill | 57 | 2017 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review